drugset / Trial / NCT01207414
Switching to Iloperidone From Other Antipsychotics in Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic treatment of risperidone, olanzapine, or aripiprazole due to suboptimal efficacy and/or safety/tolerability reasons.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | 12 mg | Oral |
| Subject | Iloperidone | Small molecule | 24 mg | Oral |